A COMPARISON OF SODIUM LEVELS IN PATIENTS SWITCHED FROM OXCARBAZEPINE TO ESLICARBAZEPINE ACETATE

被引：0
|
作者：
Oehl, B. [1 ]
Carius, A. [1 ]
Fauser, S. [1 ]
Lanz, M. [1 ]
Leonhardt, G. [1 ]
Schulze-Bonhage, A. [1 ]
机构：
[1] Univ Hosp Freiburg, Epilepsy Ctr, Freiburg, Germany
来源：
EPILEPSIA | 2011年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [21] The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice
    Landmark, Cecilie Johannessen
    Svendsen, Torleiv
    Dinarevic, Jasmin
    Kufaas, Ruben F.
    Reimers, Arne
    Brodtkorb, Eylert
    Baftiu, Arton
    Burns, Margrete L.
    Guptill, Jeffrey
    Johannessen, Svein I.
    THERAPEUTIC DRUG MONITORING, 2016, 38 (04) : 499 - 505
  • [22] Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide
    Hebeisen, Simon
    Pires, Nuno
    Loureiro, Ana I.
    Bonifacio, Maria Joao
    Palma, Nuno
    Whyment, Andrew
    Spanswick, David
    Soares-da-Silva, Patricio
    NEUROPHARMACOLOGY, 2015, 89 : 122 - 135
  • [23] STEADY-STATE PHARMACOKINETICS AND TOLERABILITY OF ESLICARBAZEPINE ACETATE AND OXCARBAZEPINE IN HEALTHY VOLUNTEERS
    Falcao, A.
    Vaz-Da-Silva, M.
    Nunes, T.
    Almeida, L.
    Soares-Da-Silva, P.
    EPILEPSIA, 2012, 53 : 114 - 114
  • [24] THE IMPACT OF PHARMACOKINETIC INTERACTIONS WITH ESLICARBAZEPINE ACETATE VERSUS OXCARBAZEPINE AND CARBAMAZEPINE IN CLINICAL PRACTICE
    Svendsen, T.
    Landmark, Johannessen C.
    Brodtkorb, E.
    Reimers, A.
    Baftiu, A.
    Burns, M. L.
    Johannessen, S., I
    EPILEPSIA, 2016, 57 : 171 - 172
  • [25] Switching from carbamazepine and oxcarbazepine to eslicarbazepine: reasons and results
    Bermejo Velasco, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 130 - 130
  • [26] Eslicarbazepine Acetate Sodium channel blocker, Antiepileptic drug
    Dulsat, C.
    Mealy, N.
    Castaner, R.
    Bolos, J.
    DRUGS OF THE FUTURE, 2009, 34 (03) : 189 - 195
  • [27] Long-term effects of dibenzazepines on metabolic parameters: retrospective comparison of carbamazepine, oxcarbazepine and eslicarbazepine acetate in the real real world
    Ley, Miguel
    Principe, Alesandro
    Rocamora, Rodrigo
    REVISTA DE NEUROLOGIA, 2020, 71 (02) : 54 - 60
  • [28] Analysis of Sodium Levels and Hyponatremia Events in Trials of Eslicarbazepine Acetate (ESL) in Pediatric Patients (Aged 4-17 years)
    Vaisleib, Inna
    Duchowny, Michael
    Grinnell, Todd
    Cantu, David
    Vieira, Mariana
    Ikedo, Fabio
    Li, Yan
    Blum, David
    NEUROLOGY, 2018, 90
  • [29] STEADY-STATE PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS OF ESLICARBAZEPINE ACETATE AND OXCARBAZEPINE IN HEALTHY VOLUNTEERS
    Nunes, T.
    Rocha, J. F.
    Falcao, A.
    Almeida, L.
    Soares-Da-Silva, P.
    EPILEPSIA, 2012, 53 : 195 - 195
  • [30] Abrupter Austausch von retardiertem Oxcarbazepin gegen EslicarbazepinacetatAbrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate
    B.J. Steinhoff
    E. Trinka
    A.S. Wendling
    Der Nervenarzt, 2011, 82 (6) : 764 - 767
12345